Anuncio • Mar 27
Myeco Group Ltd announced that it expects to receive AUD 2 million in funding Myeco Group Ltd has announced a private placement to issue Unsecured Series Two Convertible Note of the company to raise gross proceeds of AUD 2,000,000 on March 27, 2026. The transaction involves the investor participation of professional and sophisticated investors will be issued under the Company’s 15% placement capacity pursuant to ASX. The notes are 100% convertible into ordinary shares of the company at a conversion price value of AUD 0.019 per share and carry interest rate of 10.5%. The conversion price will be at a 15% discount to the VWAP over 14 trading days preceding the date of the conversion notice. The transaction is subject to approval of the board of directors of the company. The transaction is expected to close on March 31, 2026. Reported Earnings • Mar 02
First half 2026 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2025) First half 2026 results: AU$0.003 loss per share (improved from AU$0.004 loss in 1H 2025). Revenue: AU$7.75m (flat on 1H 2025). Net loss: AU$1.66m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings. New Risk • Jan 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$3.3m free cash flow). Earnings have declined by 49% per year over the past 5 years. Market cap is less than US$10m (AU$7.85m market cap, or US$5.26m). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change). Anuncio • Sep 11
Myeco Group Ltd, Annual General Meeting, Nov 13, 2025 Myeco Group Ltd, Annual General Meeting, Nov 13, 2025. Reported Earnings • Aug 28
Full year 2025 earnings released Full year 2025 results: Revenue: AU$15.7m (up 8.6% from FY 2024). Net loss: AU$4.96m (loss narrowed 47% from FY 2024). Board Change • Jul 22
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Anuncio • Apr 23
MyEco Group Ltd Provides an Update on Its Operational Restructure Initiatives MyEco Group Ltd. provided an update on its operational restructure initiatives. On 10 February 2025, the Company announced a strategic review of its manufacturing and production operations to support its record MyEco® branded sales growth more cost effectively, and to reposition the cost base of its manufacturing and production supply chain. The following initiatives from the operational restructure are all expected to be completed by June 2025: The ability to scale production capacity through strategic partnerships with high- end converters in south-east Asia, to reduce production costs, increase redundancy of supply chains, and increase flexibility to meet demand in different geographies - Reduced cost from the rationalisation of manufacturing assets in Malaysia - Relocation of larger pilot production equipment from Melbourne to the company's commercial plant in Nanjing, China to reduce costs for new product trials and realise efficiencies in upscaling to commercial production. Relocation of the company's head office and product development centre to lower-cost premises within Melbourne to reduce both rent and overheads The implementation of these initiatives is expected to deliver annual fixed cost savings of circa $2.5 million to $3.0 million commencing in the first quarter of fiscal year 2026. They will streamline MyEco Group's operations and scale production more efficiently with an aim to improve product margins, while minimising the requirement for capital investment. The company's fully integrated approach, utilising internal assets and key partnerships, positions MyEco Group to meet increasing demand in a cost-effective manner while maintaining the high-quality standards that the brand is known for. New Risk • Dec 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$13.7m (US$8.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (AU$13.7m market cap, or US$8.81m). Anuncio • Sep 19
SECOS Group Limited, Annual General Meeting, Nov 14, 2024 SECOS Group Limited, Annual General Meeting, Nov 14, 2024. Reported Earnings • Aug 23
Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023) Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 23 percentage points per year, which is a significant difference in performance. New Risk • Aug 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$12.5m market cap, or US$8.23m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change). New Risk • Jun 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$14.9m market cap, or US$9.92m). Anuncio • Sep 26
SECOS Group Limited, Annual General Meeting, Nov 17, 2023 SECOS Group Limited, Annual General Meeting, Nov 17, 2023, at 10:00 AUS Eastern Standard Time. Reported Earnings • Aug 25
Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022) Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. New Risk • Aug 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$35.0m market cap, or US$22.4m). Anuncio • May 25
SECOS Group Limited Appoints Natalya Jurcheshin as Non-Executive Director SECOS Group Limited announced the appointment of experienced company director and senior leader Natalya Jurcheshin to its Board as a Non-Executive Director. Ms Jurcheshin brings over twenty years' experience spanning finance, operations and strategy throughout Australia, North America, Ukraine and Russia in professional services, private and public companies, start-ups, and SMEs. Ms. Jurcheshin is a Non-Executive Director of Adacel Technologies Limited where she is the Chair of the Audit & Risk Management Committee and Remuneration Committee. She is a former CFO, Head of Operations and Company Secretary of Circadian Technologies Limited (renamed Opthea Limited) and is a qualified chartered accountant. Ms Jurcheshin has leadership experience in finance and accounting, risk management, strategy, operations, audit and assurance services and board roles. Her diverse commercial experience includes other senior roles with Antisense Therapeutics Limited Melbourne Symphony Orchestra, Arthur Andersen (now part of Ernst & Young) and NEISS Group Pty Ltd. Anuncio • Feb 20
SECOS Group Limited Launches New 95% Certified Recycled MyEcoBag The Board of SECOS Group Limited provided the market with an update on the launch of its new 95% Certified Recycled MyEco range of products. SECOS Group Limited launches a new recycled MyEco bin liner range produced from 95% soft-plastic Post-Consumer Waste which has been certified to meet Global Recycle Standards for recycling content, chain of custody, social and environmental practices, and chemical restrictions. Unlike many recycled products that are not produced from Post- Consumer Waste, MyEc recycled products offer a genuine recycling solution for soft plastics without compromising quality. The products will be offered for sale as part of the Group's MyEco range of products and will target the growing recycled product market segment, to reduce the amount of virgin plastic finding its way into environment and to reduce petroleum consumption and CO2 emissions. SECOS Group, an Australian company, will produce the MyEco 95% Recycled range in the Company's Asian manufacturing plants. The expanded range further aligns SECOS insupporting the Australian Government's environmental policy of "Reuse, Recycle or Compost" as stated in the Australian National Plastic Plan and mirrors policy in many other key markets around the world in the fight to reducing the amount of single use plastic in environment. Reported Earnings • Feb 17
First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022) First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Price Target Changed • Nov 16
Price target decreased to AU$0.17 Down from AU$0.20, the current price target is provided by 1 analyst. New target price is 31% above last closing price of AU$0.13. Stock is down 59% over the past year. The company is forecast to post a net loss per share of AU$0.001 next year compared to a net loss per share of AU$0.0058 last year. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Anuncio • Oct 26
SECOS Group Limited, Annual General Meeting, Nov 30, 2022 SECOS Group Limited, Annual General Meeting, Nov 30, 2022, at 10:00 AUS Eastern Standard Time. Reported Earnings • Aug 26
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jul 12
Price target decreased to AU$0.20 Down from AU$0.29, the current price target is provided by 1 analyst. New target price is 60% above last closing price of AU$0.13. Stock is down 62% over the past year. The company is forecast to post a net loss per share of AU$0.004 compared to earnings per share of AU$0.0051 last year. Board Change • Jul 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. No independent directors (5 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Anuncio • Jun 17
SECOS Group Limited Announces the Retirement of David Wake as a Non-Executive Director on 30 June 2022 The Board of SECOS Group Limited announced that Mr. David Wake will retire as a Non-Executive Director on 30 June 2022. Mr. Wake has served the Company for four years since his appointment on 16 July 2018 and during that time contributed significantly to SECOS' strategic direction, governance and provided valuable advice on industry matters. Anuncio • May 12
SECOS Group Ordinary Shares to Be Deleted from Other OTC SECOS Group Limited Ordinary Shares will be deleted from Other OTC effective from May 11, 2022, due to Inactive Security. Anuncio • Apr 20
Woolworths Expands SECOS Products to 970 Stores The Board of SECOS Group provided the market with an update on progress of its MyEcoBag® commercialisation activities. MyEcoTM success within Woolworths stores, together with the expansion into other distributors and retail chains supports the Board's strategic investment decision to expand in the retail market and the extra investment incurred in FY22. These investments are expected to achieve positive returns in the coming year. The availability of SECOS' compostable bags via Woolworths stores will give more households participating in approved council food organic waste programs the option to dispose of the bags and food waste in their green waste bin. The use of SECOS' compostable bags offers households a clean and convenient way to assist with the separation of their food waste which is critical to ensure food does not end up in landfill. The success of MyEcoTM branded products is becoming a material subcategory within the Company's total bioplastic bag sales. The expansion into 970 Woolworths stores has validated the Board's decision to invest extra funds into developing a global retail brand during a period when the Company was experiencing a range of global challenges (Covid-19 related rising freight and input costs, shipping delays, Covid lockdowns in some ports and severe floods experienced at one of the Company's manufacturing hubs). SECOS will continue to execute its growth strategy and expects returns to flow through to the bottom line as trading conditions normalize. The Company will also benefit from improving economies of scale through increased utilisation of the Company's new Malaysian plant which was launched in January this year. SECOS continues to develop further opportunities for growth in new markets for its branded MyEcoBag® and MyEcoPet® line of products and is working to garner market share in grocery and convenience stores in Australia, the USA, Latin America and elsewhere. Anuncio • Apr 12
SECOS Group Limited Announces Change of Corporate Head Office Address SECOS Group Limited announced that it has relocated its corporate head office to Mount Waverley, Victoria. The new head office will be co-located with the company's new Global Bioplastics Research and Development Centre. Major Estimate Revision • Mar 03
Consensus revenue estimates fall by 10% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from AU$43.0m to AU$38.5m. Forecast losses increased from AU$0.01 to AU$0 per share. Chemicals industry in Australia expected to see average net income growth of 33% next year. Consensus price target down from AU$0.45 to AU$0.40. Share price rose 10% to AU$0.27 over the past week. Anuncio • Jan 24
SECOS Launches MyEcoBag® & MyEcoPet® Through Pacchini Sales & Distribution SECOS Group Limited provided the market with an update on progress of its MyEcoBag® and MyEcoPet® commercialization activities. SECOS is launching new MyEcoPet® SKU's with Pacchini consisting of the two-roll pack plus dispenser and the four-roll pack. With nearly 5 million dogs in Australia and approximately 40% of Australian households owning a dog, SECOS will begin to penetrate independent Stores backed by a well-known and reputable distributor such as Pachinni. Additionally, Pacchini will launch two new bin-liner SKU's into food waste diversion market, a certified compostable 12 litre and 28 litre bin liner SKU's, adding to their existing 8 litre and 36 litre SKU's currently available through Woolworths stores. Reported Earnings • Aug 13
Full year 2021 earnings released The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Breakeven Date Change • Jun 30
Forecast breakeven pushed back to 2022 The analyst covering SECOS Group previously expected the company to break even in 2021. New forecast suggests the company will make a profit of AU$5.70m in 2022. Average annual earnings growth of 103% is required to achieve expected profit on schedule. Price Target Changed • May 05
Price target increased to AU$0.37 Up from AU$0.28, the current price target is an average from 2 analysts. New target price is 72% above last closing price of AU$0.21. Stock is up 264% over the past year. Recent Insider Transactions • Mar 04
Executive Director recently bought AU$307k worth of stock On the 2nd of March, Stephen Walters bought around 1m shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$636k more in shares than they bought in the last 12 months. Price Target Changed • Feb 24
Price target raised to AU$0.28 Up from AU$0.23, the current price target is an average from 2 analysts. The new target price is 8.1% below the current share price of AU$0.31. As of last close, the stock is up 313% over the past year. Analyst Estimate Surprise Post Earnings • Feb 23
Revenue beats expectations, earnings disappoint Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 90%. Over the next year, revenue is forecast to grow 50%, compared to a 15% growth forecast for the Chemicals industry in Australia. Is New 90 Day High Low • Feb 10
New 90-day high: AU$0.35 The company is up 100% from its price of AU$0.17 on 12 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share. Recent Insider Transactions • Feb 05
Executive Chairman recently bought AU$60k worth of stock On the 4th of February, Richard Tegoni bought around 200k shares on-market at roughly AU$0.30 per share. This was the largest purchase by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months. Is New 90 Day High Low • Jan 21
New 90-day high: AU$0.24 The company is up 48% from its price of AU$0.17 on 23 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.49 per share. Is New 90 Day High Low • Jan 06
New 90-day high: AU$0.21 The company is up 19% from its price of AU$0.18 on 08 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share. Is New 90 Day High Low • Nov 18
New 90-day high: AU$0.20 The company is up 24% from its price of AU$0.17 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.44 per share. Anuncio • Sep 24
SECOS Group Limited Secures a Strategic Distribution Agreement with Infinite Source of Ideas SECOS Group Limited (‘the Company’) announced that it has secured a strategic distribution agreement with ISOI ‘Infinite Source Of Ideas’. Under the agreement, ISOI will act as the Company's exclusive distributor in Latin America for the sale of CardiaTM Bioplastic resins to local converters. ISOI have already supplied several convertors with CardiaTM resins who have produced compostable bags for major local retailers. Distribution and trials of resins to local converters has resulted in a ramp up of demand with initial commercial orders exceeding $1.5m and due for delivery in the December quarter. Anuncio • Sep 17
SECOS Group Limited announced that it has received AUD 14.861974 million in funding On September 16, 2020, SECOS Group Limited (ASX:SES) closed the transaction. The company issued 87,423,379 ordinary fully paid shares for gross proceeds of AUD 14,861,974.43 in the transaction. The transaction included participation from individual investor Don Haller Jr. for 811,920 shares for AUD 138,026.40 and other investors. Anuncio • Sep 09
SECOS Group Limited announced that it expects to receive AUD 15.0008 million in funding SECOS Group Limited (ASX:SES) announced private placement of 88,240,000 shares at a price of AUD 0.17 per share for gross proceeds of AUD 15,000,800 on September 9, 2020. The transaction will include participation from leading institutions and existing shareholders and a wide group of institutional investors including Don Haller Jr. for $100,000 (AUD 138,402.60), subject to approval of shareholders at annual general meeting. The transaction is expected to settle on September 14, 2020. The transaction has been approved by the board of directors of the company. The transaction was oversubscribed. Anuncio • Aug 16
SECOS Group Limited to Report Q4, 2020 Results on Aug 27, 2020 SECOS Group Limited announced that they will report Q4, 2020 results at 10:18 PM, GMT Standard Time on Aug 27, 2020